In the granulomas of non-vaccinated subjects treated with PZA in the presence or absence of L-GSH, there was a significant increase of LC3B levels in all categories treated with L-GSH compared to the control and the categories without L-GSH treatment (Figure 7C). The gene discussed is MAP1LC3B; the disease is Granuloma.